His primary areas of investigation include Internal medicine, Immunology, Odds ratio, Virology and Reverse-transcriptase inhibitor. His Internal medicine research integrates issues from Gastroenterology, Lipodystrophy, Endocrinology and Viral load. His Immunology course of study focuses on Cohort and Cancer, Immunodeficiency, Genome-wide association study, Coronary artery disease and Family history.
His Odds ratio research incorporates elements of Incidence, Confidence interval, Complication, Immunopathology and Meningococcal disease. Paracrine signalling, Mitochondrion and Hormone is closely connected to Nucleoside Reverse Transcriptase Inhibitor in his research, which is encompassed under the umbrella topic of Virology. His research in Reverse-transcriptase inhibitor focuses on subjects like Nevirapine, which are connected to Dosing and HIV-associated lipodystrophy.
Internal medicine, Immunology, Gastroenterology, Virology and Surgery are his primary areas of study. Pere Domingo has included themes like Lipodystrophy, Endocrinology, Viral load and Ritonavir in his Internal medicine study. His Lipodystrophy research is multidisciplinary, relying on both Adipose tissue, Stavudine and Lipoatrophy.
His study on Immunology also encompasses disciplines like
Pere Domingo mainly focuses on Internal medicine, Immunology, Ritonavir, Antiretroviral therapy and Pharmacology. His research in Internal medicine intersects with topics in Gastroenterology, Endocrinology and Viral load. His work in Immunology covers topics such as Proportional hazards model which are related to areas like Hazard ratio, Confidence interval and Oncology.
His research on Ritonavir also deals with topics like
Pere Domingo mostly deals with Internal medicine, Ritonavir, Endocrinology, Gastroenterology and Immunology. His specific area of interest is Internal medicine, where Pere Domingo studies Regimen. The study incorporates disciplines such as Protease inhibitor, Lopinavir and Cholesterol in addition to Ritonavir.
His Endocrinology research incorporates themes from FGF21 and Inflammation. The various areas that Pere Domingo examines in his Gastroenterology study include Lean body mass, Case-control study and Bone mineral, Peak bone mass, Osteoporosis. His Immunology research includes elements of Infectious disease and Proportional hazards model.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Maria J Buzón;Marta Massanella;Josep M Llibre;Anna Esteve.
Nature Medicine (2010)
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Cristina Tural;Lidia Ruiz;Christopher Holtzer;Jonathan Schapiro.
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
François Raffi;Hans Jaeger;Eugenia Quiros-Roldan;Helmut Albrecht.
Lancet Infectious Diseases (2013)
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
Esteban Martínez;Juan A. Arnaiz;Daniel Podzamczer;David Dalmau.
The New England Journal of Medicine (2003)
Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy.
Pere Domingo;Xavier Matias-Guiu;Ramón M. Pujol;Esther Francia.
Smallpox: The Triumph over the Most Terrible of the Ministers of Death
Nicolau Barquet;Pere Domingo.
Annals of Internal Medicine (1997)
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.
Frank A Post;Graeme J Moyle;Hans Jürgen Stellbrink;Pere Domingo.
Journal of Acquired Immune Deficiency Syndromes (2010)
Severe Nucleoside-Associated Lactic Acidosis in Human Immunodeficiency Virus–Infected Patients: Report of 12 Cases and Review of the Literature
Vicente Falcó;Dolors Rodríguez;Esteban Ribera;Esteban Martínez.
Clinical Infectious Diseases (2002)
HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
Marta Giralt;Pere Domingo;Jordi P Guallar;M Luísa Rodríguez de la Concepción.
Antiviral Therapy (2006)
Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.
Joanne Reekie;Csaba Kosa;Frederik Engsig;Antonella d'Arminio Monforte.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: